Please login to the form below
White
This page shows the latest White news and features for those working in and with pharma, biotech and healthcare.
White House unveils plans to reimport medicines from Canada
The idea has always been staunchly opposed by previous Presidents, health secretaries and FDA commissioners, ostensibly on safety grounds, but the White House has broken with this orthodoxy in order to ... PhRMA had been in support of proposals to ban
Latest news
-
AZ and Novartis ‘most exposed’ to Senate pricing proposals
voted down in committee last week, but is said to be still very much on the White House agenda.
-
Another setback on pricing as Trump drops rebate plans
Based on careful analysis and thorough consideration, the President has decided to withdraw the rebate rule,” said a White House spokesman.
-
Trump presses on with reference pricing plan for medicines
The White House has been talking about this type of reference pricing for prescription drugs since the administration published a blueprint for pricing controls last year, which focused on capping US ... Sometimes by 60-70%,” he told reporters at the
-
Prime minister contenders urged to embrace NHS-style social care funding
They need to publish a White Paper [ie firmer legislation plans] not a Green Paper, with clear proposals for change now.
-
Amicus forms gene therapy manufacturing partnership with Catalent
Biotech invests to speed gene therapies into clinical trials. US biotech Amicus Therapeutics is to work with drug development services company Catalent Biologics to develop its cell and gene therapy manufacturing capabilities. It has been investing
More from news
Approximately 2 fully matching, plus 460 partially matching documents found.
Latest Intelligence
-
Pharma industry consensus: fix data strategy before pushing artificial intelligence and machine learning applications
Source: PharmaFuture Digital Council. Stay up to date on industry white papers and events at.
-
The fight for affordable insulin
Where previous administrations were opposed to importation from Canada and elsewhere, the Trump White House says it is in favour of individuals resorting to these measures, but wants to legislate to
-
Re-imagining content supply chains for a next-gen customer experience in pharma
Source: PharmaFuture Digital Council. Stay up to date on industry white papers and events at.
-
For trials without tribulations, we must improve patient experience
The result of this consultation is Havas Lynx Group’s latest white paper‘Patient Centricity on Trial’. ... Faze’s Mark Evans explains the simple but transformative insight that runs through the white paper.
-
25 Women Leaders in UK Healthcare (part 2)
We need men to speak up for the unfairness and inequity in this gap and at the same time we need white women to speak up for their black and minority ... ethnic (BME) sisters, because across the board BME people earn less than their white counterparts;
More from intelligence
Approximately 0 fully matching, plus 44 partially matching documents found.
Latest appointments
-
Ron Menezes joins Almirall’s Aqua Pharmaceuticals
Menezes will replace Ted White, who has been president and general manager of Aqua Pharmaceuticals since January 2016.
-
VCLS appoints Carole Jones to senior market access role
strategy, development of manuscripts and white papers for peer-reviewed journals, systematic literature reviews, global value dossiers and interactive field-based assets.
-
Eli Lilly appoints senior VP for corporate affairs and communications
Prior to joining AIA, Pusey had been the deputy assistant to President George Bush for the White House Office of Public Liaison and deputy director of communications for the Republican National
-
IFPMA appoints Fumie Griego as assistant director general
Prior to that Griego spent time at the White House as its senior economist where she provided US officials in both the Bush and Obama administrations with advice on a range
-
McCann Health expands consulting team
Goodman also worked for the White House office on reform and health policy during both the Clinton and Obama administrations.
More from appointments
Approximately 0 fully matching, plus 12 partially matching documents found.
Latest from PMHub
-
Report: Customer experience, shaping digital healthcare
In this issue of ‘Perspective’ we speak with industry experts to learn about the world of digital healthcare, and how pharma is beginning to utilise these modern technologies to enhance treatment and improve patient and stakeholder outcomes. For
-
Programmatic methodology and why you should be using it
We are then able to ensure that we’re ABPI compliant, by only running across a white-list of websites and targeting the appropriate audience across them, we can reach the
-
Can you survive without the blue dot?
Or has the digital world has replaced our brain. Have we become totally incompetent? Are we now at the stage where we are unable to do even simple tasks like reading a map or ordering a coffee? The physical world has become increasingly reliant on
-
Patient centricity: Reality or rhetoric?
Everybody is talking about patient centricity, but what does it mean for those involved in market research, insights and business intelligence? We spoke to some of our clients from major and mid-size pharmaceutical companies to find out what it
-
Device Attribute Testing
Our client wanted to determine the optimal new blood glucose monitoring device – one that would best retain their current customers and also attract new ones. They also wanted to be able to rationalise the strengths of their existing portfolio
More from PMHub
Approximately 9 fully matching, plus 1,080 partially matching documents found.
Featured jobs
- Account Manager – Healthcare advertising
-
Salary TBC
- Account Manager, Healthcare Communications
-
£32, 000 - £40, 000 bonus benefits
-
Account Director – UK Office
-
Excellent salary and benefits
-
Senior Medical Writer
-
Competitive salary plus benefits
- Client Services Director- Flexible Working
-
Negotiable
-
Events Executive
-
DOE
Subscribe to our email news alerts
- Novartis eyes potential new indication for Cosentyx
- J&J's Tremfya filed for approval in US for psoriatic arthritis
- AbbVie/Allergan's merger faces public opposition
- Envision Pharma Group relocates to support expansion
- Biogen loses another pipeline drug to toxicity concerns
- AZ, Merck’s Lynparza scores market-expanding clinical success
- Report: Customer experience, shaping digital healthcare
- The benefits of uniting in a divergent environment
- Encouraging signs in biomarker R&D
- J&J puts pressure on rivals with new Erleada okay in prostate cancer
- Pharma exhibition stand design with added value
- Bluebird Bio reveals further encouraging data for CALD gene therapy
PMHub
bmore group
OUR PROMISE: BETTER HEALTH FROM TRIAL TO TREATMENT.We are a full service, independent network of specialist agencies under one roof....
Latest intelligence
- Report: Customer experience, shaping digital healthcare
- In this issue of ‘Perspective’ we speak with industry experts to learn about the world of digital healthcare, and how pharma is beginning to utilise these modern technologies to enhance...
- Encouraging signs in biomarker R&D
- The cancer immunotherapy firms ramping-up biomarker R&D...
- Programmatic methodology and why you should be using it
- What is it? How does it work? Why is everyone talking about it? By Richard Webb - Associate Director...
Quick links
Infographics
